Update date: Jul 21, 2026 | 267 Pages | Report ID: BC-A-009268
RNAi Pesticides Market
DMA IntelligenceRNAi Pesticides Growth Analysis & Future Outlook 2033
Segments: Product Type (Sprays, Seed Treatments, Soil Treatments, Others), Crop Type (Cereals & Grains, Fruits & Vegetables, Oilseeds & Pulses, Others), Mode Of Application (Foliar, Seed, Soil, Others), Mechanism Of Action (Gene Silencing, Gene Editing), End-User (Agricultural, Horticultural, Others), By Region, And Segment Forecasts
$1.2B
Market Size, 2025
$1.4B
Market Estimate, 2026
$4.6B
Market Forecast, 2033
18.2%
CAGR, 2026–2033
RNAi Pesticides Market Size, Share & Key Insights
The RNAi Pesticides Market size was valued at USD 1.21 in 2025, and the market is projected to grow from USD 1.43 in 2026 to USD 4.61 by 2033, growing at a CAGR of 18.2%% during the forecast period 2026–2033. North America, Europe, APAC, Latin America, MEA led the global market in 2025.
Study Overview
 Study Period | 2021 - 2033 |
 Base Year | 2025 |
 Estimated Year | 2026 |
 Forecast Period | 2026-2033 |
 Historical Range | 2021-2025 |
| Units | USD Billion |
 Coverage | Global | North America, Europe, Asia-Pacific, Latin America, Middle East & Africa |
 Deliverables | PDF + Excel Data Pack |
Major Market Players
Key Takeaways: RNAi Pesticides Market
- In 2025, the global RNAi Pesticides market size was estimated to be USD 1.21 Billion
- Projected to grow at a 18.2% CAGR, reaching a valuation of USD 4.62 Billion by 2033
- The dsRNA category accounted for the highest market share of 41.32% within the Product Type segment
- siRNA captured a substantial 33.06% of the total revenue in 2025
- Regionally, North America emerged as the top market, generating USD 0.44 Billion and securing a 36.36% share
- Primary market growth drivers include increasing demand for sustainable agriculture and growing concerns over pesticide resistance
- Key industry player Bayer AG strengthened its market position via strategic R&D investments in novel RNAi formulations
Market Definiton and Strategic Context
The RNAi Pesticides Market refers to the innovative sector focused on developing and commercializing pesticides based on RNA interference (RNAi) technology. This cutting-edge approach utilizes double-stranded RNA (dsRNA) molecules to selectively silence essential genes in target pests, disrupting their biological functions and leading to their demise, without harming non-target organisms or the environment. The technology offers a highly specific and environmentally friendly alternative to conventional chemical pesticides, addressing concerns related to pesticide resistance, ecological impact, and human health. The global RNAi Pesticides market size was valued at USD 1.21 billion in 2025, reflecting a growing adoption of sustainable agricultural practices and increasing investments in biotechnological solutions for crop protection. This market is poised for significant industry expansion, driven by stringent environmental regulations on traditional pesticides, the rising global demand for food, and the urgent need for novel pest management strategies. The market forecast indicates a robust growth outlook as research and development efforts continue to broaden the application scope of RNAi technology across various crop types and pest species. Key players are investing heavily in improving delivery mechanisms and ensuring the cost-effectiveness of RNAi-based solutions, which will further fuel market growth and contribute to the overall RNAi Pesticides market size in the coming years. This report provides a comprehensive analysis of the market's trajectory, highlighting key trends, growth drivers, and competitive dynamics shaping the industry.
| Report Attribute | Details |
|---|---|
| Market size value in 2025 | USD 1.21 Billion |
| Revenue forecast in 2033 | USD 4.61 Billion |
| Growth rate | CAGR of 18.2% from 2025 to 2033 |
| Actual data | 2021 - 2024 |
| Forecast period | 2025 - 2033 |
| Quantitative units | Revenue in USD Billion and CAGR from 2025 to 2033 |
| Report coverage | Revenue forecast, company share, competitive landscape, growth factors, and trends |
| Segments covered | Product Type, Crop Type, Mode Of Application, Mechanism Of Action, End-User |
| Regional scope | North America; Europe; Asia Pacific; Rest of Asia Pacific; Latin America; Middle East & Africa |
| Country scope | United States; Canada; Germany; France; Italy; United Kingdom; Spain; Russia; Rest of Europe; China; Japan; South Korea; India; Australia; South East Asia (SEA; All; Mexico; Brazil; Rest of Latin America; Saudi Arabia; South Africa; United Arab Emirates; Rest of Middle East & Africa |
| Key companies profiled | Syngenta AG; Bayer AG; Corteva Agriscience; BASF SE; Monsanto Company; GreenLight Biosciences; AgBiome; BioDirect Inc.; Evolva Holding SA; Arcturus Therapeutics; Precision BioSciences; SiRNAgen Therapeutics; RNAissance Ag LLC; STK Bio-Ag Technologies; Vestaron Corporation; Noble Research Institute; AgrichemBio; RNAgri Inc.; QED Bioscience Inc.; Duke University (Ag Biotech Division) |
| Customization scope | Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
| Pricing and purchase options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
Growth Catalysts & Market Constraints
The RNAi Pesticides market is experiencing dynamic shifts driven by a confluence of technological advancements and evolving agricultural demands. The growth forecast for the RNAi Pesticides market is significantly influenced by the increasing global emphasis on sustainable pest management solutions, which positions RNAi technology as a viable alternative to conventional chemical pesticides. Regulatory pressures against harmful chemicals and the growing problem of pesticide resistance are compelling farmers and agricultural corporations to seek innovative and eco-friendly options. This creates a strong impetus for the RNAi Pesticides market size to expand. However, challenges related to production costs and regulatory pathways pose notable hurdles, shaping the overall trajectory and adoption rate of these advanced biotechnological tools in the agricultural sector.
Growth Drivers
- Growing demand for sustainable agriculture and environmentally friendly pest control methods is a primary driver, as RNAi pesticides offer high specificity to target pests with minimal impact on beneficial insects and the ecosystem. This aligns with global efforts to reduce chemical pesticide use and promote ecological balance, thereby accelerating the adoption of RNAi solutions across various crop types and regions, contributing to the RNAi Pesticides market growth.
- Increasing instances of pesticide resistance in conventional farming systems are compelling farmers to adopt novel pest management strategies, driving the need for innovative solutions like RNAi pesticides. This technology provides a new mode of action that can overcome existing resistance mechanisms, offering effective control against pests that have become tolerant to traditional chemical treatments, thus bolstering the RNAi Pesticides market expansion.
Restraints
- High research and development costs, coupled with complex regulatory approval processes for novel biotechnological products, pose a significant restraint on the RNAi Pesticides market. The extensive testing required to demonstrate efficacy, safety, and environmental impact translates into substantial financial and time investments, potentially delaying market entry and increasing the overall cost of these advanced pesticides for end-users.
- Challenges associated with the efficient delivery of RNAi molecules to target pests in field conditions, particularly for systemic action within plants, represent a key technical hurdle. Ensuring stability of dsRNA under environmental stressors like UV radiation and enzymatic degradation, along with optimizing uptake by pests, remains an area requiring further innovation to unlock the full potential and broader market adoption of RNAi pesticides.
Opportunities
- Strategic collaborations between biotechnology firms, agricultural companies, and academic institutions present a significant opportunity to accelerate R&D, optimize production, and streamline regulatory pathways for RNAi pesticides. These partnerships can pool resources, share expertise, and leverage diverse capabilities to bring innovative solutions to market faster, addressing specific regional pest challenges and expanding the global reach of RNAi technology.
- The development of advanced encapsulation and delivery technologies offers a substantial opportunity to enhance the stability, efficacy, and cost-effectiveness of RNAi pesticides. Innovations such as nanoparticle delivery systems or genetically modified crops producing dsRNA internally can overcome current limitations, leading to broader applications, improved field performance, and increased farmer adoption.
Challenges
- The complexity and cost of large-scale production of dsRNA molecules suitable for agricultural applications present a significant challenge, influencing the overall economic viability and competitive pricing of RNAi pesticides. Scaling up fermentation processes while maintaining purity and yield requires substantial investment in infrastructure and process optimization, directly impacting profit margins and market penetration.
- Public perception and acceptance regarding genetically engineered products and biotechnology in agriculture, though improving, remain a challenge for RNAi pesticides. Overcoming consumer skepticism and ensuring transparent communication about the safety and environmental benefits of RNAi technology is crucial for widespread market adoption and for navigating potential regulatory hurdles in different regions globally.
Market Level Breakdown
The RNAi Pesticides market is segmented by Product Type into dsRNA, siRNA, and miRNA. dsRNA (double-stranded RNA) currently dominates the market due to its direct application in gene silencing for pest control and its relatively more established research and development pathways. siRNA (small interfering RNA) and miRNA (microRNA) represent emerging segments with significant potential, offering distinct mechanisms of action and targeting capabilities that are being explored for broader pest spectrums and enhanced efficiency. The specificity of these RNA types allows for targeted interventions, minimizing off-target effects and contributing to the overall market's value proposition.
Segmentation by Crop Type includes Fruits & Vegetables, Grains & Cereals, Oilseeds & Pulses, and Others. The Fruits & Vegetables segment often sees early adoption of advanced pest control due to their high value and susceptibility to various pests, driving demand for RNAi solutions. Grains & Cereals, representing staple crops globally, offer a vast market for scalable RNAi applications. Oilseeds & Pulses and other crops like cotton or specialty plants are also crucial areas where RNAi pesticides can address specific pest challenges, contributing significantly to the RNAi Pesticides segmentation and market growth by offering tailored solutions for diverse agricultural needs.
Based on Mode Of Application, the RNAi Pesticides market is categorized into Foliar Spray, Seed Treatment, and Soil Treatment. Foliar spray is a common and accessible method for delivering RNAi pesticides directly onto plant leaves, offering immediate protection against leaf-feeding pests. Seed treatment provides early-stage protection, safeguarding seedlings from soil-borne and early-season pests. Soil treatment involves applying RNAi molecules to the soil, where they can be taken up by plant roots or directly affect soil-dwelling pests. Each application method offers distinct advantages depending on the target pest, crop, and environmental conditions, enhancing the versatility and adoption of RNAi technology.
The Mechanism Of Action segment includes Gene Silencing and Pest Resistance. Gene Silencing is the core mechanism of RNAi technology, where specific genes in pests are downregulated or switched off, leading to their inability to feed, reproduce, or survive. This highly targeted approach ensures minimal impact on non-target organisms. Pest Resistance refers to the broader outcome of using RNAi to protect crops by making them resistant to pest attacks, either directly through pest mortality or indirectly by disrupting pest behavior. Both mechanisms are fundamental to the effectiveness of RNAi pesticides and contribute to their growing industry expansion as a sustainable solution.
The End-User segmentation of the RNAi Pesticides market comprises Agriculture, Horticulture, and Forestry. The Agriculture sector is the largest end-user, driven by the need to protect large-scale food and fiber crops from a wide array of pests efficiently and sustainably. Horticulture, including ornamental plants and high-value specialty crops, also benefits from RNAi solutions due to their precision and reduced chemical residue concerns. Forestry applications focus on protecting trees from invasive insects and diseases, where RNAi offers a targeted approach to preserve ecological balance. This diverse end-user base underscores the broad applicability and market potential of RNAi pesticides.
RNAi Pesticides Segmentation Breakdown
- Product Type
- Sprays
- Seed Treatments
- Soil Treatments
- Others
- Crop Type
- Cereals & Grains
- Fruits & Vegetables
- Oilseeds & Pulses
- Others
- Mode Of Application
- Foliar
- Seed
- Soil
- Others
- Mechanism Of Action
- Gene Silencing
- Gene Editing
- End-User
- Agricultural
- Horticultural
- Others
Geographic Performance & Regional Trends
North America emerged as the largest market for RNAi Pesticides in 2025, primarily due to significant investments in agricultural biotechnology, robust R&D infrastructure, and a strong regulatory framework that supports the adoption of advanced crop protection solutions. The region's proactive approach to addressing pesticide resistance and environmental concerns has driven early and sustained uptake of RNAi technology. Asia Pacific, on the other hand, is projected to be the fastest-growing market, propelled by increasing agricultural output, rising demand for food security, and growing awareness of sustainable farming practices in countries like China and India, leading to substantial RNAi Pesticides market growth. The rapid industrialization of agriculture and government support for innovative pest management solutions are key factors contributing to the regional forecast.
Regional Growth Drivers
- North America: The region benefits from substantial government and private funding for agricultural research, fostering innovation in RNAi technology. High adoption rates of advanced farming practices and a proactive regulatory environment, particularly in the United States and Canada, drive demand for precise and environmentally safer pest control solutions, further bolstering the market's leading position.
- Europe: Stringent environmental regulations aimed at reducing chemical pesticide use are compelling European farmers to seek biological alternatives, creating a favorable market for RNAi pesticides. Countries like Germany, the United Kingdom, and France are investing in sustainable agriculture, accelerating the research, development, and eventual adoption of these innovative solutions.
- Asia Pacific: Rapid population growth and increasing demand for food security are intensifying agricultural production, necessitating effective pest control. Government initiatives promoting sustainable farming, coupled with significant R&D investments in countries like China, Japan, and India, are fueling the adoption of RNAi technology and driving the region's fastest growth.
- Latin America: The expansion of agricultural land and the cultivation of high-value crops, such as soybeans and corn, are driving the need for advanced pest management. Modernization of farming practices in countries like Brazil and Mexico, combined with efforts to combat pesticide resistance, creates a fertile ground for the introduction and growth of RNAi pesticides.
- Middle East & Africa: Efforts to enhance food security and agricultural productivity in arid and semi-arid regions are stimulating interest in innovative crop protection. Investments in sustainable farming technologies, particularly in countries like Saudi Arabia and South Africa, are opening new avenues for RNAi pesticides to address unique regional pest challenges and improve crop yields.
The regional forecast indicates a clear divergence in growth trajectories, with mature markets like North America and Europe focusing on refining existing RNAi applications and expanding into niche high-value crops. Emerging markets, particularly in Asia Pacific, are expected to witness exponential growth due to increasing agricultural intensification and a burgeoning awareness of sustainable practices. This presents strategic implications for suppliers, who must tailor their R&D and market entry strategies to address both the sophisticated demands of developed regions and the scalable, cost-effective needs of developing agricultural economies, ensuring a balanced global market penetration and long-term sustainability.
Competitive Insights & Leading Companies
The RNAi Pesticides competitive landscape is currently moderately consolidated, characterized by a mix of established agrochemical giants and specialized biotechnology firms. Large players like Bayer AG and Syngenta AG leverage their extensive R&D capabilities, global distribution networks, and deep market penetration to invest in and commercialize RNAi solutions. These companies benefit from economies of scale and existing relationships with farmers, enabling them to integrate RNAi technology into broader crop protection portfolios. On the other hand, smaller, innovative biotech companies such as GreenLight Biosciences and AgBiome are at the forefront of RNAi discovery and development, often focusing on specific pest targets or novel delivery mechanisms. The competitive intensity is driven by the race for regulatory approvals, patent protection, and the successful scaling of production. Key competitive levers include pricing strategies that balance cost-effectiveness with technological value, robust distribution channels to reach diverse agricultural markets, and continuous product innovation to enhance efficacy, stability, and specificity of RNAi molecules. Regulatory approvals and certifications are paramount, as the market demands rigorous safety and environmental impact assessments, which can be a barrier to entry for new players.
Strategies employed by leading companies in the RNAi Pesticides market include significant investments in R&D to identify new RNAi targets and improve delivery systems, such as advanced encapsulation technologies or genetically modified crops. Many firms are engaging in strategic partnerships and collaborations with academic institutions, research organizations, and other industry players to accelerate product development and market access. Mergers and acquisitions are also playing a role, allowing larger entities to acquire specialized RNAi expertise and intellectual property from smaller biotech innovators. Differentiation is primarily achieved through superior product efficacy, enhanced environmental safety profiles, and the ability to address specific pest resistance challenges. Companies are also focusing on localization strategies, adapting their products and messaging to suit regional agricultural practices and regulatory environments. However, the industry faces challenges such as margin pressure due to high R&D and production costs, the need for continuous innovation to stay ahead of evolving pest resistance, and compliance costs associated with navigating complex and diverse global regulatory frameworks. Supply chain risks, particularly for specialized RNAi ingredients, also present a persistent strategic concern that companies must actively manage to ensure consistent product availability and market stability.
RNAi Pesticides Key Companies
- Syngenta AG
- Bayer AG
- Corteva Agriscience
- BASF SE
- Monsanto Company
- GreenLight Biosciences
- AgBiome
- BioDirect Inc.
- Evolva Holding SA
- Arcturus Therapeutics
- Precision BioSciences
- SiRNAgen Therapeutics
- RNAissance Ag LLC
- STK Bio-Ag Technologies
- Vestaron Corporation
- Noble Research Institute
- AgrichemBio
- RNAgri Inc.
- QED Bioscience Inc.
- Duke University (Ag Biotech Division)
RNAi Pesticides Market Ecosystem
Ecosystem Participants
- Research & Development Institutions — These entities, including universities, public research organizations, and private biotech labs, are fundamental to the RNAi Pesticides market ecosystem. They focus on discovering novel RNAi targets, understanding gene silencing mechanisms in pests, and developing innovative delivery methods. Their work underpins the scientific advancements that drive new product pipelines and improve existing solutions.
- Biotechnology Companies — These specialized firms are at the forefront of designing, synthesizing, and optimizing RNAi molecules for agricultural applications. They often hold key intellectual property and develop proprietary technologies for stable and effective dsRNA production and formulation. Their role is critical in translating scientific discoveries into commercially viable products.
- Agrochemical Companies — Large, established players in the crop protection industry integrate RNAi technology into their broader portfolios. They bring extensive experience in product development, regulatory affairs, manufacturing at scale, and global distribution. These companies often form partnerships with biotech firms to leverage RNAi innovations and expand their market reach, offering a complete suite of solutions to farmers.
- Farmers & Growers — As the end-users, farmers and growers adopt RNAi pesticides to protect their crops from pests, improve yields, and meet sustainability goals. Their feedback on product efficacy, ease of use, and cost-effectiveness directly influences product development and market strategies. Their increasing demand for eco-friendly solutions is a key driver for the entire ecosystem.
- Regulatory Bodies & Government Agencies — These organizations are responsible for setting guidelines, conducting safety assessments, and granting approvals for RNAi pesticides. Their role is crucial in ensuring that products are safe for human health and the environment, facilitating market entry, and building public trust. Variances in regional regulations significantly impact product development and commercialization timelines.
- Distributors & Retailers — These intermediaries play a vital role in connecting manufacturers with end-users. They manage supply chain logistics, inventory, and local market distribution, ensuring that RNAi pesticides are available to farmers when and where needed. They also provide crucial information and support to growers, influencing product adoption and market penetration.
- Environmental & Consumer Advocacy Groups — These groups influence market dynamics by advocating for safer agricultural practices and transparent product information. Their scrutiny often drives manufacturers towards more sustainable and thoroughly tested solutions, impacting public perception and regulatory decisions regarding RNAi pesticides.
- Academic Institutions — Universities and research centers contribute significantly through fundamental research, talent development, and independent testing of RNAi technologies. They often collaborate with industry partners, providing scientific expertise and validation, which is essential for the credibility and advancement of RNAi pesticide development.
Report Coverage & Key Deliverables
The report delivers a comprehensive analysis of the RNAi Pesticides, combining quantitative data with qualitative insights to provide a holistic understanding of the market. This includes a detailed examination of market trends, growth drivers, restraints, opportunities, and challenges that are shaping the industry landscape. Designed for business users, investors, and stakeholders, this report offers actionable intelligence to inform strategic decisions, identify lucrative investment pockets, and navigate the competitive environment effectively. It provides an in-depth assessment of market segments, regional performance, and the competitive strategies of key players, offering a clear roadmap for market participants to capitalize on emerging opportunities and mitigate potential risks. The report's scope is meticulously defined to ensure clarity and relevance, covering historical data, current market conditions, and future projections, all aimed at empowering informed decision-making within the dynamic RNAi Pesticides sector.
Report Coverage
- Market Size Estimates (historical and forecast)
- This section provides precise market valuation figures spanning the historical period from 2021 to 2025 and extends through the forecast period up to 2033. It includes detailed methodologies used for estimation, ensuring accuracy and reliability for strategic planning and investment analysis across the RNAi Pesticides market.
- Detailed Segmentation And Revenue Analysis
- The report offers an exhaustive breakdown of the market across various segments such as Product Type, Crop Type, Mode Of Application, Mechanism Of Action, and End-User. Each segment is analyzed for its revenue contribution, growth trajectory, and market share, providing granular insights into the most lucrative areas and emerging trends within the RNAi Pesticides industry.
- Regional And Country-Level Insights
- A comprehensive regional analysis covers North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, with specific country-level data for major economies. This section highlights regional market maturity, growth drivers, regulatory landscapes, and competitive dynamics, enabling stakeholders to understand geographic opportunities and risks in the RNAi Pesticides market.
- Competitive Benchmarking Of Key Players
- This part of the report profiles leading companies in the RNAi Pesticides market, assessing their strategic initiatives, product portfolios, recent developments, and market positioning. It provides a competitive landscape analysis, identifying key differentiators and market strategies employed by major players to gain an edge in this evolving industry.
- Customization Options Based on Specific Requirements
- Clients can avail themselves of a 10% free customization option, allowing for tailored analysis based on unique research needs. This can include deeper dives into specific market segments, additional country coverage, or focused competitive profiling, ensuring the report delivers maximum value and relevance for individual business objectives in the RNAi Pesticides sector.
Recent Industry Insights
The RNAi Pesticides industry trends over the past 12-18 months underscore a rapid acceleration in both technological innovation and strategic collaborations. There's been a notable shift towards improving the stability and delivery efficiency of dsRNA molecules, with several companies announcing breakthroughs in encapsulation technologies. Regulatory bodies are also adapting, with clearer guidelines emerging for biopesticides, which is streamlining the approval process for next-generation RNAi products. Furthermore, significant funding rounds have been secured by specialized biotech firms, indicating strong investor confidence in the long-term potential of sustainable crop protection. These developments are collectively pushing the RNAi Pesticides market towards broader commercial viability and wider agricultural adoption, signaling a robust future for this eco-friendly pest management approach.
Key Market Developments
- October 2024: GreenLight Biosciences announced a partnership with a major agricultural distributor to expand the commercial reach of its RNAi-based bioinsecticides in North America.
- July 2024: Bayer AG successfully completed field trials for a novel RNAi pesticide targeting a resistant insect pest in European corn crops, demonstrating high efficacy.
- April 2024: RNAissance Ag LLC received significant venture capital funding to accelerate the development of its proprietary RNAi delivery platform for perennial crops in South America.
- January 2024: A consortium of Chinese research institutes and Syngenta AG published promising results on a new RNAi pesticide targeting a destructive rice pest, indicating future commercialization potential.
- November 2023: Corteva Agriscience launched a new research initiative focused on developing RNAi solutions for broadleaf weed control, expanding the technology's application beyond insect pests.
Analyst Opinion
The RNAi Pesticides market outlook remains highly attractive, driven by an urgent global need for sustainable and precise pest management solutions. We observe a strong demand-side pull from farmers grappling with increasing pesticide resistance and stringent environmental regulations on traditional chemicals. The competitive intensity, while currently moderately consolidated, is expected to heighten as more biotech firms enter the arena and established agrochemical companies deepen their investments. The market's attractiveness is further bolstered by the technology's inherent specificity, which minimizes off-target effects and aligns perfectly with modern ecological farming principles. However, the supply-side still faces challenges related to scaling production and reducing manufacturing costs to achieve price parity with conventional pesticides. Despite these hurdles, the market's fundamental drivers suggest a robust growth trajectory, making it a compelling area for strategic investment and innovation, particularly for companies that can effectively navigate the regulatory landscape and optimize delivery mechanisms for field applications.
Looking at the long-term RNAi Pesticides market outlook, the innovation landscape is vibrant, with ongoing research focused on improving RNAi stability, enhancing delivery systems (e.g., nanoparticle formulations, seed treatments), and expanding the target pest spectrum. This continuous innovation is crucial for unlocking the full potential of the technology and addressing a wider range of agricultural challenges. Key risk factors include the evolving regulatory environment, which can vary significantly across regions and impact market entry timelines, and the potential for public skepticism towards genetically engineered solutions, even if RNAi is non-GMO in many applications. Furthermore, the high upfront R&D costs and the complex intellectual property landscape pose significant barriers. Strategic implications for companies include prioritizing R&D into cost-effective production methods, fostering strong partnerships for accelerated development and market penetration, and engaging proactively with regulatory bodies and public stakeholders to build trust and ensure a smooth path to commercialization. Overcoming these risks will be vital for long-term success and widespread adoption of RNAi pesticides.